Neuronetics, Inc.
STIMNASDAQHealthcare● Active
$1.28
$-0.01(-0.78%)
Market Cap$89072384
P/E Ratio—
52W High$4.85
52W Low$0.8
Neuronetics, Inc. (STIM) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
STIM · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 5, 2026EPS Actual
-$0.16
Est. -$0.17 · +5.9%
Revenue
$0.03B
Est. $0.03B · +0.8%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 5, 2026
After Market Close
▲ Beat EPS✓ 2-Quarter EPS Beat Streak
STIM reports quarterly as a NASDAQ-listed Medical - Diagnostics & Research company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.21
Rev. $0.66B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.21
Rev. Est.$0.66B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 4, 2026 | -$0.11 | — | — | — | $0.04B | — |
| ▲ Q2 FY2026 | May 5, 2026 | -$0.17 | -$0.16 | +5.9% | $0.03B | $0.03B | +0.8% |
| ▲ Q1 FY2026 | Mar 17, 2026 | -$0.12 | -$0.10 | +16.7% | $0.04B | $0.04B | +2.7% |
| ▼ Q4 FY2025 | Nov 4, 2025 | -$0.12 | -$0.13 | -8.3% | $0.04B | $0.04B | -1.4% |
| ▼ Q3 FY2025 | Aug 5, 2025 | -$0.08 | -$0.15 | -87.5% | $0.04B | $0.04B | +0.7% |
| ▼ Q2 FY2025 | May 6, 2025 | -$0.13 | -$0.21 | -61.5% | $0.03B | $0.04B | -12.6% |
| ▼ Q1 FY2025 | Mar 4, 2025 | -$0.26 | -$0.33 | -26.9% | $0.02B | $0.03B | -21.9% |
| ▼ Q4 FY2024 | Nov 12, 2024 | -$0.23 | -$0.29 | -26.1% | $0.02B | $0.02B | -3.1% |
Q3 FY2026
Aug 4, 2026
EPS Actual
—
EPS Est.
-$0.11
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 5, 2026Beat
EPS Actual
-$0.16
EPS Est.
-$0.17
EPS Surpr.
+5.9%
Revenue
$0.03B
Q1 FY2026
Mar 17, 2026Beat
EPS Actual
-$0.10
EPS Est.
-$0.12
EPS Surpr.
+16.7%
Revenue
$0.04B
Q4 FY2025
Nov 4, 2025Miss
EPS Actual
-$0.13
EPS Est.
-$0.12
EPS Surpr.
-8.3%
Revenue
$0.04B
Q3 FY2025
Aug 5, 2025Miss
EPS Actual
-$0.15
EPS Est.
-$0.08
EPS Surpr.
-87.5%
Revenue
$0.04B
Q2 FY2025
May 6, 2025Miss
EPS Actual
-$0.21
EPS Est.
-$0.13
EPS Surpr.
-61.5%
Revenue
$0.03B
Q1 FY2025
Mar 4, 2025Miss
EPS Actual
-$0.33
EPS Est.
-$0.26
EPS Surpr.
-26.9%
Revenue
$0.02B
Q4 FY2024
Nov 12, 2024Miss
EPS Actual
-$0.29
EPS Est.
-$0.23
EPS Surpr.
-26.1%
Revenue
$0.02B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $-0.07 | $-0.07 | $-0.07 | 1 |
| Q3 FY2027 | $-0.09 | $-0.09 | $-0.09 | 1 |
| Q2 FY2027 | $-0.09 | $-0.09 | $-0.09 | 1 |
| Q1 FY2027 | $-0.10 | $-0.10 | $-0.09 | 1 |
| Q4 FY2026 | $-0.08 | $-0.07 | $-0.07 | 1 |
| Q3 FY2026 | $-0.11 | $-0.11 | $-0.11 | 2 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 5, 2026 | +5.9% | $2.02 | $2.17 | +7.43% |
| ▲ Q1 FY2026 | Mar 17, 2026 | +16.7% | $1.36 | $1.23 | -9.56% |
| ▼ Q4 FY2025 | Nov 4, 2025 | -8.3% | $2.77 | $2.87 | +3.61% |
| ▼ Q3 FY2025 | Aug 5, 2025 | -87.5% | $4.66 | $4.55 | -2.36% |
| ▼ Q2 FY2025 | May 6, 2025 | -61.5% | $4.50 | $4.50 | +0.00% |
| ▼ Q1 FY2025 | Mar 4, 2025 | -26.9% | $4.26 | $5.06 | +18.78% |
| ▼ Q4 FY2024 | Nov 12, 2024 | -26.1% | $1.10 | $0.69 | -37.27% |
| ▼ Q3 FY2024 | Aug 12, 2024 | -22.2% | $1.78 | $0.75 | -58.15% |
Q2 FY2026+7.43%
Report Date
May 5, 2026
EPS Beat/Miss
+5.9%
Price Before
$2.02
Price After
$2.17
Q1 FY2026-9.56%
Report Date
Mar 17, 2026
EPS Beat/Miss
+16.7%
Price Before
$1.36
Price After
$1.23
Q4 FY2025+3.61%
Report Date
Nov 4, 2025
EPS Beat/Miss
-8.3%
Price Before
$2.77
Price After
$2.87
Q3 FY2025-2.36%
Report Date
Aug 5, 2025
EPS Beat/Miss
-87.5%
Price Before
$4.66
Price After
$4.55
Q2 FY2025+0.00%
Report Date
May 6, 2025
EPS Beat/Miss
-61.5%
Price Before
$4.50
Price After
$4.50
Q1 FY2025+18.78%
Report Date
Mar 4, 2025
EPS Beat/Miss
-26.9%
Price Before
$4.26
Price After
$5.06
Q4 FY2024-37.27%
Report Date
Nov 12, 2024
EPS Beat/Miss
-26.1%
Price Before
$1.10
Price After
$0.69
Q3 FY2024-58.15%
Report Date
Aug 12, 2024
EPS Beat/Miss
-22.2%
Price Before
$1.78
Price After
$0.75
Avg Beat Reaction-1.07%
Avg Miss Reaction-12.56%
Beat Rate2 / 8 quarters
Largest Move-58.15% (Q3 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: STIM ends December
Neuronetics, Inc. (STIM) most recently reported earnings on May 5, 2026 for Q2 FY2026, posting EPS of $-0.16 — beating the analyst consensus of $-0.17 by +5.9%. STIM has beaten EPS estimates for 2 consecutive quarters. The next STIM earnings date is expected around September 1, 2026.
Each quarter, investors track STIM earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. STIM revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
STIM's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
STIM earnings · 5 questionsNeuronetics, Inc.'s next earnings report is expected around September 1, 2026. STIM typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; STIM historically reports after market close (AMC).
STIM earnings datewhen is STIM earningsSTIM next earnings datewhen does STIM report earningsSTIM earnings calendar
▸ Source: FMP · Neuronetics, Inc. SEC filings · US GAAP · Neuronetics, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026